AUTOIMMUNE THYROID DISORDER

AUTOIMMUNE THYROID DISORDER was reported 109 times

AUTOIMMUNE THYROID DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD52-directed Cytolytic Antibody [EPC] 23 0.0012
1 Chemokine Receptor Type 4 Interaction [EPC] 1 0.0007
2 Interferon alfa-2b [EPC] 1 0.0005
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 33 0.0003
4 CTLA-4-directed Blocking Antibody [EPC] 7 0.0001
5 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
6 Cephalosporin Antibacterial [EPC] 1 0.0001
7 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
8 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
9 Sympathomimetic-like Agent [EPC] 2 0.0001
10 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
11 Human Immunoglobulin G [EPC] 1 0.0000
12 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
13 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
14 Protease Inhibitor [EPC] 2 0.0000
15 gamma-Aminobutyric Acid-ergic Agonist [EPC] 4 0.0000
16 beta3-Adrenergic Agonist [EPC] 2 0.0000
17 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
18 Purine Antimetabolite [EPC] 4 0.0000
19 Ester Local Anesthetic [EPC] 2 0.0000
20 PCSK9 Inhibitor [EPC] 1 0.0000
21 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 4 0.0000
22 Anti-IgE [EPC] 3 0.0000
23 Provitamin D2 Compound [EPC] 1 0.0000
24 Phenothiazine [EPC] 1 0.0000
25 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
26 Interleukin-23 Antagonist [EPC] 3 0.0000
27 Potassium Channel Blocker [EPC] 2 0.0000
28 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
29 Non-Standardized Chemical Allergen [EPC] 2 0.0000
30 Platinum-based Drug [EPC] 7 0.0000
31 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
32 Integrin Receptor Antagonist [EPC] 2 0.0000
33 General Anesthetic [EPC] 1 0.0000
34 Amide Local Anesthetic [EPC] 2 0.0000
35 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
36 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
37 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
38 Antiarrhythmic [EPC] 2 0.0000
39 Microtubule Inhibitor [EPC] 3 0.0000
40 Complement Inhibitor [EPC] 1 0.0000
41 BCL-2 Inhibitor [EPC] 1 0.0000
42 HER2/neu Receptor Antagonist [EPC] 1 0.0000
43 Aldosterone Antagonist [EPC] 2 0.0000
44 Catecholamine [EPC] 1 0.0000
45 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
46 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
47 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
48 Interferon beta [EPC] 2 0.0000
49 Proton Pump Inhibitor [EPC] 6 0.0000
50 Osmotic Laxative [EPC] 3 0.0000
51 Interleukin-12 Antagonist [EPC] 1 0.0000
52 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
53 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
54 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
55 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
56 Opioid Agonist [EPC] 2 0.0000
57 Benzodiazepine [EPC] 5 0.0000
58 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
59 alpha-Adrenergic Blocker [EPC] 1 0.0000
60 Progestin [EPC] 2 0.0000
61 beta-Adrenergic Blocker [EPC] 2 0.0000
62 Kinase Inhibitor [EPC] 3 0.0000
63 Estrogen [EPC] 1 0.0000
64 Platelet Aggregation Inhibitor [EPC] 3 0.0000
65 Thiazide Diuretic [EPC] 1 0.0000
66 Corticosteroid [EPC] 6 0.0000
67 Mood Stabilizer [EPC] 1 0.0000
68 Anti-epileptic Agent [EPC] 1 0.0000
69 Insulin Analog [EPC] 2 0.0000
70 Alkylating Drug [EPC] 1 0.0000
71 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
72 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
73 Factor Xa Inhibitor [EPC] 1 0.0000
74 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
75 GLP-1 Receptor Agonist [EPC] 1 0.0000
76 Atypical Antipsychotic [EPC] 1 0.0000
77 Tumor Necrosis Factor Blocker [EPC] 1 0.0000